California Healthcare Institute on patent reform

An IPBiz reader noted a discussion of patent reform issues ["Impact of Patent Law Changes on Biomedical Investment and Innovation"] by the California Healthcare Institute (CHI).

The divergence between IT and BIO folks on patent issues has been noted for some time.

For example, on the controversial "second window" for post-grant review:
http://ipbiz.blogspot.com/2007/04/second-window-post-grant-review-comes.html

Pharma on KSR v. Teleflex:
http://ipbiz.blogspot.com/2007/05/newark-star-ledger-on-ksr-impact-on.html
http://ipbiz.blogspot.com/2007/05/biotechpharma-reaction-to-ksr-decision.html